In recent years, a number of studies analyze the relationship between the markers of tumor stem cells CD133, Nestin and prognosis of patients with glioma, but due to differences in research method, sample size and the study population, the findings of a single sample are difficult to extend to the entire population and the obtained conclusions are inconsistent. This evidence concerns the gene NES and neoplasm.